Mankind Pharma's domestic business revenues grew by 16 per cent year-on-year, reaching Rs 2,773 crore in Q3FY25, compared to Rs 2,400 crore in Q3FY24. The company’s consumer healthcare segment saw a ...

On a consolidated basis, the companys net sales value (NSV) for the quarter stood at Rs 3,433 crore, marking a 14.4% YoY growth. Additionally, EBITDA showed strong growth, rising by 16.9% YoY to Rs ...

Despite the decline in profit, the quarter 3 results exceeded Street expectations, with net profit surpassing the estimated ...

With the introduction of these new offerings, Jio has phased out its previous Rs 1,899 plan, which provided 24GB of data with ...

Goldman Sachs reportedly has maintained a 'Buy' rating and increased its target price to Rs 12,580, up from Rs 12,460, citing volume recovery and lower costs contributing to margin improvement ...

Shares of firms like ICICI Bank, IndiGo, NTPC, UltraTech, Adani Wilmar, and others will be in focus on Friday's trade ...

The scam reportedly amassed over Rs 2,200 crore from individuals across 20 states. The funds, considered "proceeds of crime," were transferred abroad, but Rs 500 crore was frozen by the ED while in ...

Consolidated net profit stood at Rs 2,543.65 crore in October-December 2024 - the third quarter of April 2024 to March 2025 fiscal year (FY25) - compared with Rs 712.84 crore earning in the same ...

The company said profit rose due to a strong EBITDA growth and was boosted by the reversal of net deferred tax liability of Rs 185 crore mainly due to divestment in Dahanu Plant in AEML.

Karamtara Engineering Ltd filed a DRHP with SEBI for an IPO, seeking ₹1,350 crore in fresh equity and ₹400 crore from ...

HYDERABAD: The TelanganaRising delegation, led by Chief Minister A Revanth Reddy, concluded its trip to the World Economic Forum (WEF) Annual Meeting in Davos o ...

Indus Towers posted a consolidated net profit of Rs 4,003 crore in Q3 2024-25, driven by robust tower and colocation additions, and significant overdu ...